ARTICLE | Company News
Beyond Genomics, GSK systems biology deal
January 28, 2004 8:00 AM UTC
GlaxoSmithKline (LSE:GSK; GSK) agreed to fund Beyond Genomics' systems biology research to identify biomarkers for metabolic diseases. Under the deal, Beyond Genomics receives an upfront fee, and is e...